Renal and Nonrenal Clearance of Clodronate in Patients with Malignancy and Renal Impairment

This publication has 19 references indexed in Scilit:

• Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
  Journal of Clinical Oncology, 1993
• Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1989
• Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1989
• Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and Hypercalcemia
  Published by Springer Nature ,1989
• A One Year Follow‐Up Study of the Distribution of ¹⁴C‐Clodronate in Mice and Rats
  Basic & Clinical Pharmacology & Toxicology, 1988
• The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma
  British Journal of Haematology, 1983
• LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
  The Lancet, 1983
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982
• The pathophysiology of hypercaemia
  Metabolic Bone Disease and Related Research, 1980
• The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat
  The Anatomical Record, 1979